C2i Genomics

C2i Genomics

C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.

Key Info

  • 2019 Founded2019 Founded
  • New York, New York, United StatesNew York, New York, United States
  • 66 Employees66 Employees
  • LinkedIn•••••••••
    Lock Closed

Credibility

LinkedIn Verified
LinkedIn Verified

News

There are no recent news for this organization.

Activity Timeline

There is no recent activity for this organization.

Team

Investments

There is no investment data on this organization.

Similar Companies